AAAAAA

   
Results: 1-3 |
Results: 3
PHARMACOKINETICS OF ITRACONAZOLE ORAL SOLUTION IN ALLOGENEIC BONE-MARROW TRANSPLANT PATIENTS RECEIVING TOTAL-BODY IRRADIATION
Authors: MICHALLET M PERSAT F KRANZHOFER N LEVRON JC PRAT C BELHABRI A CHWETZOFF E LEMOING JP FIERE D PIENS MA
Citation: M. Michallet et al., PHARMACOKINETICS OF ITRACONAZOLE ORAL SOLUTION IN ALLOGENEIC BONE-MARROW TRANSPLANT PATIENTS RECEIVING TOTAL-BODY IRRADIATION, Bone marrow transplantation, 21(12), 1998, pp. 1239-1243
PHARMACOKINETICS OF ITRACONAZOLE (ORAL SOLUTION) IN 2 GROUPS OF HUMANIMMUNODEFICIENCY VIRUS-INFECTED ADULTS WITH ORAL CANDIDIASIS
Authors: REYNES J BAZIN C AJANA F DATRY A LEMOING JP CHWETZOFF E LEVRON JC
Citation: J. Reynes et al., PHARMACOKINETICS OF ITRACONAZOLE (ORAL SOLUTION) IN 2 GROUPS OF HUMANIMMUNODEFICIENCY VIRUS-INFECTED ADULTS WITH ORAL CANDIDIASIS, Antimicrobial agents and chemotherapy, 41(11), 1997, pp. 2554-2558
EXAMPLE OF ACTIVE THERAPEUTIC DRUG-MONITO RING - ITRACONAZOLE
Authors: LEVRON JC LEMOING JP CHWETZOFF E
Citation: Jc. Levron et al., EXAMPLE OF ACTIVE THERAPEUTIC DRUG-MONITO RING - ITRACONAZOLE, Therapie, 51(5), 1996, pp. 502-506
Risultati: 1-3 |